DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Genzyme
Genzyme
National Lipid Association Annual Summary of Clinical Lipidology 2016 Disclosures Dr. Harold E. Bays: Dr. Bays Discloses That He
Executive Profile: Genzyme's CEO on Dark Times, Transition and the Long
Dyax Corp. 300 Technology Square Cambridge, MA 02139 617 225-2500
Cerezyme, INN-Imiglucerase
Publication of Recordals of Assignment, Change of Name
Concert Management
PPCO Twist System
Does M&A Create Value in the Pharmaceutical Sector?
China Rare Disease Market: Large and Untapped Opportunity
Exploring Technological Change in the German Pharmaceutical Industry
Client List LATEST
Annual Report on Form 20-F 2018
Development of Therapeutic Antibodies for the Treatment Of
NEWSLETTER May 2015, Volume XXV, No
ASMS Directory of Members
Imiglucerase in the Treatment of Gaucher Disease: a History and Perspective
Sanofi 2020 R&D Day Presentation
Acquisition Agreement for Genzyme
Top View
Corporate Presentation
Annual Report of Form 20-F 2019
Concert Management
CP.PHAR.154 Imiglucerase (Cerezyme)
COPY Sanofi Begins $18.5-Bn Hostile Offer for Genzyme
Annual Report on Form 20-F 2011
Abbreviation of Manufacturers' Names 4/30/02